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Abstract

Background
The Advisory Committee on Immunization Practices recommend childbearing-aged
women receive an annual influenza vaccine, one dose of Tdap instead of TD after 18 years of
age, and one dose of Tdap during the 3rd trimester of each pregnancy. Despite these
recommendations, influenza and Tdap vaccination rates remain lower than current goals.
Objectives
The purpose was to assess influenza and Tdap vaccination rates among women of
childbearing age by pregnancy status, age group, and race/ethnicity.
Methods
The retrospective secondary data analysis included a nationally representative sample of
women aged 18 to 44 years from the 2014 Behavioral Risk Factors Surveillance System, a
national health-related telephone survey of non-institutionalized adults ≥18 years old.
Descriptive statistics and X2 analysis were performed to estimate vaccination rates and compare
them among the stratified groups with alpha set as 0.01 for this study.
Results
There were 66,894 childbearing-aged women and 3.8% of them were pregnant during
data collection. Thirty-seven percent received an influenza vaccination within the past 12 months
and 59.0% received a Tdap vaccination within the recommended time frame. Pregnancy status,
age group, and race/ethnicity were predictors of influenza vaccination receipt among
childbearing-aged women. Similarly, age group and race/ethnicity were predictors of Tdap
vaccination receipt among childbearing-aged women. However, pregnancy status was not a
predictor of Tdap vaccination receipt among childbearing-aged women.
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Conclusions
Both influenza and Tdap vaccination rates among childbearing aged women were lower
than the national goals. Further research is needed to identify barriers to vaccinations in this
population.
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Background

Standard vaccination programs in the United States have traditionally focused on children
immunization programs. With recent outbreaks of vaccine preventable diseases, such as
influenza and pertussis, recommendations suggested increasing focus on adult vaccination
interventions to improve vaccination coverage and maintain herd immunity (Williams, et al.,
2016). In particular, the Advisory Committee on Immunization Practices (ACIP) recommended
pregnant women and childbearing-aged women (18-44 years) receive an annual influenza
vaccine, one dose of Tdap instead of TD after turned 18 years of age, and one dose of Tdap
during the 3rd trimester (27-36 weeks gestation) of each pregnancy (Annunziata, Rak, Del Buono,
DiBonaventura, Krishnarajah, 2012; Centers for Disease Control and Prevention (CDC), 2013;
HealthyPeople 2020, 2016; Kharbanda, Parker, Nordin, Hedblom, & Rolnick, 2013).
Recommendations were developed as both influenza and pertussis pose significantly increased
risk for complications to pregnant woman, fetuses, and newborns (O’Halloran, Lu, Williams,
Ding, & Meyer, 2016; Yuen & Tarrant, 2014).
Despite these recommendations, influenza and Tdap vaccination rates remained lower
than current goals among adults in the United States. Current national influenza vaccination
goals were 70% while current estimations suggest only 38% of the total United States of
America population receives the vaccination annually (HealthyPeople 2020, 2016). In recent
studies of the 2013-2014 influenza season, among adults greater than 19 years, the influenza
vaccination rate was 46.7%; and the rate was approximately 50% of pregnant women of all ages
(Henninger, et al., 2015; Williams, et al., 2016). Age related discrepancies were also noted with
individuals 65 years or older receiving the most vaccinations by percentage (Williams, et al.,
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2016). In addition, racial disparities existed with whites receiving significantly more vaccines
than blacks, Hispanics, and Asians (Williams, et al., 2016).
Similar to influenza vaccination rates, Tdap vaccination rates have remained consistently
low among adults in the United States despite increased focus on vaccinating all adults in order
to protect infants (under 1 year) and meet the Healthy 2020 (2016) goal to reduce pertussis
among infants by at least 10%. Among individuals >19 years, 62.2% received any tetanus toxoid
vaccination in the past 10 years and 20.1% received a Tdap vaccination in the past 9 years (Lu,
O’Halloran, Ding, Liang, & Williams, 2016). In addition, 14% of pregnant women received the
Tdap vaccine during their pregnancy (Kharbanda, et al., 2016). Adults aged 19-64 years old were
more likely to receive a Tdap vaccine than any other age group (Williams, et al., 2016). Similar
to influenza vaccination, whites were more likely to receive Tdap vaccination than blacks,
Hispanics, and Asians (Williams, et al., 2016).
Problem Statement
While the current data offered some evidence about adult immunization rates, limited
studies were available focusing on influenza and Tdap vaccination rates among childbearingaged women (18-44 years). Understanding influenza and Tdap vaccination rates among
childbearing-aged woman was needed as pregnant women and infants suffered greater health
consequences from both influenza and pertussis (Kharbanda, et al., 2016; Lu, et al., 2016).
Following current vaccination recommendations would greatly reduce the risk of respiratory
illness among pregnant women, preterm birth, small-for-gestational age birth, and respiratory
illness and subsequent hospitalization for pregnant women and infants less than 6 months of age
(Baxter, Bartlett, Fireman, Lewis, & Klein, 2017; O’Leary, et al., 2015; Rosenbaum, McBane,
Wang, & Sawyer, 2014). In addition, cocooning infants by vaccinating all individuals in close
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proximity of the infant with influenza and Tdap vaccines provides a protective effect to infants
(O’Leary, et al., 2015). Despite these facts, the reported influenza and Tdap vaccination rates
remained below national standards set by HealthyPeople 2020 (2016). Additionally, limited
information was available regarding influenza and Tdap vaccination rates among childbearingaged women, as most studies focus on all adults and do not further describe the vaccination rates
among this population by pregnancy status, age groups based on advanced maternal age, or
racial/ethnic groups.
Purpose
In the United States, slightly more than 6.3 million pregnancies occurred annually with
49% of these pregnancies being unintended (CDC 2015d; CDC, 2016a). Since the current
recommendations encouraged childbearing-aged women to maintain up-to-date vaccinations in
case a pregnancy occurs, an analysis of influenza and Tdap vaccination rates among
childbearing-aged women could aid in intervention development with the goal to improve
vaccination coverage and health utilization in this population. One national database collecting
relevant data about influenza and Tdap vaccination rates was the Behavioral Risk Factor
Surveillance System (BRFSS). The BRFSS could be sorted by many different factors including
gender, race/ethnicity, location, etc. Therefore, through an analysis of a national database,
researchers could identify demographic subsets among childbearing-aged women with low
influenza and Tdap vaccination rates to develop and implement targeted interventions to improve
vaccination among these high-risk groups. Thus, the purpose of this project was to assess
influenza and Tdap vaccination rates among childbearing-aged women (18-44 years) by
pregnancy status (pregnant versus non-pregnant), age group (18-34 years and 35-44 years), and
race/ethnicity group (white, black, Hispanic, Asian).
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Specific Aims

Within the 2014 Behavioral Risk Factor Surveillance System (BRFSS):
1. Identify and compare influenza and Tdap vaccination rates among childbearing-aged
women who were pregnant and those who were not.
2. Identify and compare influenza and Tdap vaccination rates among childbearing-aged
women by age group.
3. Identify and compare influenza and Tdap vaccination rates among childbearing-aged
women by race/ethnicity.
Hypothesis
Among a nationally representative sample of childbearing-aged women:
1. There is a difference in influenza vaccination rates among women who are pregnant and
those who are not.
2. There is a difference in Tdap vaccination rates between women who are pregnant and
those who are not.
3. There is a difference in influenza vaccination rates between women who were 18-34
years and those who were 35-44 years.
4. There is a difference in Tdap vaccination rates between women who were 18-34 years
and those who were 35-44 years.
5. There is a difference in influenza vaccination rates among whites, blacks, Hispanics, and
Asians.
6. There is a difference in Tdap vaccination rates among whites, blacks, Hispanics, Asians.
Significance
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Among all individuals living in the United States, each year approximately 5-20%
contracts influenza (Molinari, et al., 2007). In 2014, pertussis cases reached an all time high of
32,974 incident cases (CDC, 2016b). In 2015, there were 20,762 per 100,000 incident cases
reported by the CDC (2017) and suggested the rates of pertussis were improving with increased
vaccination rates. These infections, if occurred among pregnant women, can cause serious
consequence for these women and their infants. Specific influenza consequences among pregnant
women included pneumonia, increased mortality in the third trimester, and increased risk of
hospitalization from cardiorespiratory illness (Fortner, Kuller, Rhee, & Edwards, 2012; Yuen &
Tarrant, 2014). Consequences seen among fetuses and infants born to mothers with influenza
included greater likelihood of small for gestational age, increased mortality, increased
teratogenic effects, such as cleft lip and palate, neural tube defects and cardiovascular
malformations, and increased risk for schizophrenia (Yuen & Tarrant, 2014). Regarding pertussis,
young infants were at greatest risk for severe disease complications such as apnea, pneumonia,
seizures, and death (Gall, 2012; Suryadevara & Domachowske, 2015). Adults’ disease related
symptoms include protracted coughing illness with subconjunctival hemorrhages, weight loss,
urinary incontinence, syncope, and rib fractures (Suryadevara & Domachowske, 2015).
Therefore, it is imperative to find ways to improve influenza and Tdap vaccination rates among
childbearing-aged women and women who are pregnant to prevent negative consequences of
contracting the disease.
Limited information had been previously published regarding influenza and Tdap
vaccination rates among childbearing-aged women. Influenza and Tdap vaccination rates among
childbearing-aged women need to increase to meet Healthy 2020 goals. Therefore, an analysis of
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the 2014 BRFSS vaccination data among childbearing-aged women offered a broad perspective
of vaccination coverage in this population via analysis of a large national database.
Previous quality improvement projects have demonstrated increases in overall
vaccination rates through a multi-component design (Fu, et al., 2012; Lam, George, Dunlow,
Nelson, & Hartzell, 2013). Yet, to design targeted interventions, baseline data are needed. The
results from this study could provide nursing professionals with an improved understanding of
vaccination status in pregnant women as well as childbearing-aged women. In addition, the data
could assist them to identify high-risk groups in need of additional intervention to improve
influenza and Tdap vaccination rates. This would enable them to develop targeted interventions
and/or quality improvement projects to improve vaccination rates and improve herd immunity
for this crucial population.
Literature Review Criteria
Peer-reviewed published articles were identified through MESH terms and keyword
searches from 2012 to present in the following databases: MEDLINE, SCOPUS, and CINAHL.
MESH terms used in conjunction with Boolean connectors included “women,” “influenza,”
“Tdap,” “vaccination,” and “immunization.” Other keywords used included pregnancy, pregnant,
race, racial disparity, age, and age disparity. Reference lists of identified articles were also
searched for relevant peer-reviewed articles. Articles were included for review if they were
written in English, published between 2012-2016, studied a population in the United States, or
were a review article. Of the 357 articles identified, 20 were relevant and were included in this
discussion.
Literature Review
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Annually, ACIP assessed the adult immunization schedule and provided new
recommendations and changes as necessary (Annunziata, et al., 2012; Lu, et al., 2015b; Lu,
O’Halloran, & Williams, 2015a). In recent years, several notable changes have been made for
one specific population, childbearing-aged women. In particular, recommendations for two
vaccinations, influenza and Tdap, have changed in the past 12 years. Current recommendations
suggested all adults to receive an annual influenza vaccination in the fall of each year (Williams,
et al., 2016). To further clarify the recommendation, ACIP recommended an annual influenza
vaccination for all pregnant women during any trimester in 2004 (Rasmussen, Watson, Kennedy,
Broder, & Jamieson, 2014). In 2005, ACIP recommended women of childbearing age receive a
Tdap vaccination as a one-time replacement for tetanus & diphtheria (Td) vaccination prior to
conception (Kharbanda, et al., 2016; Rasmussen, et al., 2014). In 2012, an ACIP committee met
and updated the Tdap recommendation to prevent pertussis outbreaks in children < 1 year. In
February 2013, the committee published the recommendation for all women to receive a Tdap
vaccination during every pregnancy, ideally during the third trimester greater than two weeks
prior to delivery (27-36 weeks gestation), even if the last Tdap or Td vaccination was given in
the past 10 years (Fortner, et al., 2012, Kharbanda, et al., 2016; Rasmussen, et al., 2014). Since
these recommendations were effective right after their release, data collected after 2013 should
reflect the 2013 Tdap recommendation change to vaccinate all pregnant women during the 3rd
trimester.
In recent years, safety of both influenza and Tdap vaccinations were studied among
pregnant women 14-49 years and found to be safe and without significant consequences
(DeSilva, Vazquez-Benitez, & Nordin, 2016; Sukumaran, et al., 2015; Wortman, Casey,
McIntire, & Sheffield, 2015). In addition, one study found vaccinating mother during 27-36
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weeks gestation was 85% more effective in preventing pertussis in infants less than 8 weeks old
than when the vaccination was given at any other point during the pregnancy (Winter, Nickell,
Powell, & Harriman, 2016).
Pregnant and non-pregnant women
Only a few studies have assessed influenza and Tdap vaccination rates among
childbearing-aged women. In 2012, Fortner, et al., identified influenza vaccination rates among
pregnant women for the 2009-2010 influenza season as a range between 32%-64%. Koepke, et al.
(2015) analyzed data collected from January 2013 to March 2014, among 40,054 pregnant
women (11-44 years) in Wisconsin and found overall influenza vaccination rates to be 38.7%
during the study period with significant variations of influenza vaccination uptake noted among
women who delivered in and out of influenza season. When studying postpartum women,
O’Leary, et al. (2015) found a 50.5% influenza vaccination rate among 613 postpartum women
in 2013. (O’Leary, et al., 2015). All those rates were below the goal of 70% set by
HealthyPeople 2020 (Healthy People, 2016).
Vaccination rates of non-pregnant childbearing-aged women are very limited. Annunziata,
et al. (2012) examined five years of the National Health and Wellness Survey (2007 to 2011) that
included 25,000 adults (> 19 years) and found influenza vaccination rate was 54.5%. In another
study of 12,657 childbearing women during the 2010 to 2011 influenza season, Kharbanda et al.
(2013) found the influenza vaccination rate to be 39.8% but did not differentiate rates by
pregnancy status. While these studies provided some basic information, the current influenza
vaccination rate among childbearing-aged women is not available. Moreover, none of the studies
have compared influenza vaccination rates between pregnant and non-pregnant women using the
same data set collected from a nationally representative sample during the same time period.
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Therefore, an assessment of influenza vaccination rates among pregnant versus non-pregnant
was warranted.
Similar to influenza vaccination rates, minimal information on Tdap vaccination rates
among childbearing-aged women were available. From December 2010 to April 2011, Lam and
associates conducted a performance improvement project which included 3,185 women who
were of childbearing age or had frequent exposure with children treated by gynecologists at a
large military treatment facility. The authors found the Tdap vaccination rate was 13.9% during
the study period (Lam, et al., 2013). One reason for the observed low rate could be that this study
was conducted before the new recommendation issued by ACIP in 2013. . In another study, Lu,
et al. (2016) analyzed the 2013 BRFSS data and found the overall Tdap vaccination rate among
479,201 adults was 28.9%; and a rate of 51.3% for adult female participants. The authors did not
report the rate for childbearing-aged women or for pregnant women. Using data collected in
2011, another study found Tdap vaccination rates among 12,657 childbearing-aged women to be
45.5% (Kharbanda, et al., 2013). One study found significant increases (from 14% to 41.7%) in
Tdap vaccination among 438,487 pregnant women after the most recent ACIP’s recommendation
change (Kharbanda, et al., 2016). However, they did not report whether there was similar
increases among non-pregnant women. Koepke, et al. (2015) assessed Tdap vaccination receipt
among 40,054 pregnant women (11-44 years) in Wisconsin and found Tdap vaccination rates to
be 35% in this study population. Among 613 postpartum women, Tdap vaccination receipt
during pregnancy was 67% (O’Leary, et al., 2015). Finally, Suryadevara & Domachowske
(2015) reported the Tdap vaccination rates as 17.2% for the general adult population in the
United States in 2013.
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Based on a review of the literature, gaps exist regarding national influenza and Tdap
vaccination rates among pregnant and non-pregnant childbearing-aged women (18-44 years).
Some studies reported data collected before the new ACIP recommendation (Azzunziata, et al.,
2012; Fortner, et al., 2012; Kharbanda, et al., 2013; Lam, et al., 2013; Santibanez & Kennedy,
2016); while others used data from local or regional practices (Kharbanda, et al., 2016; Koepke,
et al., 2015; O’Leary, et al., 2015). Only one study reviewed national database information and
identified Tdap vaccination rates of childbearing aged women (Azzunziata, et al., 2012).
Additionally, limited data is available regarding influenza and Tdap vaccination rates among
non-pregnant childbearing-aged women. Furthermore, none of the studies have compared the
vaccination rates between childbearing-aged women who were pregnant or not pregnant using a
nationally representative sample. Therefore, an analysis regarding influenza and Tdap
vaccination rates of pregnant and non-pregnant childbearing aged women in a nationally
representative sample is warranted to identify high-risk groups in need of intervention to
improve influenza and Tdap vaccination rates.
Age group differences
The majority of information available regarding influenza and Tdap vaccination rates are
lumped into large age groups, such as ≥ 18 years old, ≥ 19 years old, ≥ 65 years old, etc. For
example, Groom, Zhang, Fisher, & Wortley (2014) reported influenza vaccination rates among
3,138 adults as 68% for white adults greater than 65 years old and 54% for black adults greater
than 65 years old, but did not stratify by gender or include women less than 65 years old. In a
study of 34,535 adults, the authors found significant differences among age groups of all adults ≥
18 years, with those greater than or equal to 65 years receiving more influenza vaccinations than
those younger than 65 years (p<0.05) (Lu, et al., 2015b). Several studies identified statistically
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significant differences among multiple age groups of adults who received the influenza and Tdap
vaccinations. Kharbanda, et al., (2013) assessed Tdap vaccination rates among 12,657 adult
women and found significant differences among vaccination frequencies by age groups: 18-26
years (reference group), 27-35 (45.6%, p<0.0002), and 36-44 years (43.2%, p<0.0001). Another
study assessing only Tdap vaccination rates among the United States adult population found that
18-49 years and 50-64 years age groups to be significantly more likely to receive the Tdap
vaccination then those ≥ 65 years (p<0.05) (Lu, et al., 2016). Williams, et al. (2016) assessed
national vaccination rates and identified significant age group differences for both influenza and
Tdap vaccination rates. For influenza, vaccination rates were significantly higher among 50-64
years and ≥ 65 years (p<0.05) (Williams, et al., 2016). Tdap vaccination rates were significantly
lower among those ≥ 65 years when compared to 19-49 years and 50-64 years age groups
(p<0.05) (Williams, et al., 2016).
Among these studies comparing vaccination rates among age groups, only one compared
age groups among women of childbearing age (Kharbanda, et al., 2013). The data collected was
from January 1, 2007 – March 31, 2011. There were no current studies that have compared
vaccination rates among age groups for this study population.
Race/ethnicity differences
Often racial disparities were noted in scientific research. A review of the literature
suggested four major racial groups most likely to receive both influenza and Tdap vaccinations
were whites, blacks, Hispanics, and Asians. Among 12,657 women, Kharbanda, et al. (2013),
found a statistically significant difference regarding influenza vaccination rates only among
blacks (30.0%, p=0.0001) when compared to non-Hispanic whites (40.7%, reference). Influenza
vaccination rates were not statistically significant among Hispanics (46.1%, p=0.59) and Asians
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(41.1%, p=0.81) when compared to white, non-Hispanics. Additionally, the authors found Asians
were less likely (78.3%, p=0.0003) to receive a Tdap vaccine than whites (82.9%, reference
category), black (84.4%, p=0.26), and Hispanics (81.7%, p=0.5755). Several studies identified
whites as more likely to receive both influenza and Tdap vaccines than blacks, Hispanics and
Asians. Lu, et al. (2015b) found significant differences by race and age group for both influenza
and tetanus/Tdap vaccinations in a sample of 479,201 adults from the 2013 BRFSS dataset.
Regarding influenza vaccination rates, non-Hispanic blacks aged 19-64 years (Adjusted
Prevalence Ratio (APR)=0.92, p<0.05) and non-Hispanic Asians aged 19-64 years (APR=1.24,
p<0.05) were less likely to receive the vaccine than whites (reference) and Hispanics of all ages
(APR=1.07, p<0.05) (Lu, et al., 2015). Regarding Tdap vaccination rates, non-Hispanic blacks
aged 19-64 years (APR=0.84, p<0.05), Asians aged 19-64 years (APR=0.84, p<0.05), and
Hispanics aged 19-64 years (APR=0.91, p<0.05) were less likely to receive Tetanus/Tdap
vaccines than non-Hispanic whites (Lu, et al., 2015). Williams, et al. (2016) also identified
significant race/ethnicity differences for both influenza and Tdap vaccination rates among all
adults (>=18 years). When compared to white, non-Hispanic adults (46.7%), blacks (36.5%,
p<0.05) and Hispanics (33.2%, p<0.05) were less likely to receive an influenza vaccine and there
was no significant difference among Asians (44.6%) (Williams, et al., 2016). When compared to
white, non-Hispanic adults (46.7%), blacks (50.7%, p<0.05), Asians (50.5%, p<0.05), and
Hispanics (52.1%, p<0.05) were less likely to receive a tetanus/Tdap vaccination (Williams, et
al., 2016). With disparities noted among vaccine receipt among all adults, an assessment of
race/ethnicity regarding receipt of influenza and Tdap vaccinations among childbearing-aged
women was needed to add to the body of literature.
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This literature review showed gaps concerning influenza and Tdap vaccination rates
among childbearing-aged women. Both vaccination rates have not been systematically compared
between pregnant and non-pregnant women and by age groups, using a nationally representative
sample. Therefore, additional research is needed to identify current influenza and Tdap
vaccination rates among women of childbearing-aged women.
Theory
The theoretical model driving this study was Andersen’s Behavioral Model of Medical
Care Utilization (Andersen & Newman, 1973). The model was originally designed to understand
health care utilization in an integrated framework by studying relationships between individuals,
providers, and the societal or environmental determinants (Andersen & Newman, 1973). The
authors discussed the importance of identifying and defining trends and relationships within
national survey data to obtain further understanding of healthcare utilization (Andersen, 1995;
Andersen & Newman, 1973). In order to understand an individual’s use of services, there were
three components to comprehend: predisposing factors, factors that contribute or impede use
(enabling factors), and need for healthcare (illness level) (Heider, et al., 2014). Predisposing
factors included socio-demographic factors such as race, age, education, income, etc. In addition
to providing information regarding health care utilization, the trends and relationships also
provided information to shape public policy and decision-making (Andersen & Newman, 1973).
Since the late 1960s, the model has been adapted and improved to adjust for changes in
health care utilization and our health care system. Figure 1 describes the current model, Phase 4.
The model outlined a feedback loop exhibiting multiple influences on health services and
ultimately health status (Andersen, 1995). This study will evaluate trends and relationships
among childbearing-aged women’s use of health services (receipt of influenza and Tdap
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vaccinations) allowing for an evaluation of health status (immunity to vaccine preventable
disease), thus aligning with Phase 4 of Andersen’s Health Utilization model. In addition, using
specific demographic variables, such as age and race/ethnicity, will highlight particular groups
who need additional intervention to improve vaccination rates; thus, increasing healthcare
utilization.
Variables
Study variables were selected from the 2014 BRFSS database (Centers for Disease
Control and Prevention (CDC), 2015a). The variable, PREGNANT, identified women who were
pregnant and those who were not during the survey (CDC, 2015a). AGE was measured as years
and divided into two age groups: 18-34 years and 35-44 years. This transformation was needed
as women 35 years or older are considered as having advanced maternal age and may be
considered higher risk for poor fetal outcomes. Race/ethnicity was measured by the variable
_RACE, which considered both race and ethnicity (CDC, 2015b). All respondents who reported
they were of Hispanic or Latino origin were listed as Hispanic (CDC, 2015b). Other racial
groups included in this analysis were non-Hispanic white (white), non-Hispanic blacks (blacks),
and non-Hispanic Asians (Asian). Demographic variables such as marital status (married/living
with a partner versus not married), number of children less than 18 years old in household
(CHILDREN), education (EDUCA), employment status (EMPLOY1), and income (INCOME2)
were also included in this study (Appendix A). Finally, _STATE was used to identify which
states utilized the TETANUS module. Appendix A outlined theoretical and operational
definitions for all variables and Appendix B lists the codebook for this study. Concept maps for
influenza and Tdap variables were located in Figures 2 & 3, respectively.
Methods
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Research Design
This retrospective secondary data analysis used a descriptive-correlational design. There
were two reasons for choosing this study. First, this design was a good fit to answer the proposed
research hypotheses as national surveillance data provides a large study population and relevant
BRFSS questions were asked to evaluate the research questions during the original telephone
survey. Second, this design was realistic and feasible as it enabled the researcher to complete the
study in the defined time period.
Setting & Sample
The 2014 BRFSS was a national health-related telephone survey of non-institutionalized
adults ≥18 years old conducted annually in all 50 states and the District of Columbia regarding
health risk behaviors, chronic disease, and use of preventative services (CDC, 2016a). Study
participants were randomly chosen through a multistep cluster design (random digit dialing) with
over 450,000 surveys completed annually (Lu, et al., 2016). The survey consisted of a core
questionnaire required for all states, additional modules, and state specific questions. Each state
had the option to include or exclude the additional modules. Therefore, not all of the additional
modules were included for each state in the BRFSS. Since 2011, landline and cellular telephones
were included in the BRFSS. The response rate for the 2014 BRFSS was 47% for both landlines
and cell phones (CDC, 2015c).
After the survey has been compiled, the resulting annual databases were managed online
in the public domain and were free and readily available for evaluation and analysis. In 2014,
there were 464,664 total participants, with almost 59% of the participants identifying as female
(CDC, 2015a). Since the data contained no identification and is in the public domain, this study
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is considered a non-human subject study and exempt from IRB review (GWU IRB
communication, 2016).
From the 2014 BRFSS data, all women aged 18 – 44 years were used in this analysis.
The inclusion criterion includes all women (answered female to the BRFSS question “Indicate
sex of respondent”), aged 18 years to 44 years, with race coded as white, black, Hispanic, and
Asian (CDC, 2015a; CDC, 2015b).
Sample Size
The 2014 BRFSS included 66,894 childbearing-aged women. We performed a power
analysis to determine the sample size needed for our hypotheses. By assuming a small effect size,
50% rate versus 55% rate, with alpha of 0.05 and power of 0.80, the minimum sample size
requirements were 1604 individuals per group for each research question (Biomath.com, n.d.).
Due to the large sample in BRFSS, we anticipated that we would have enough respondents in
each comparison group.
Instrument and Measurement
Initial data collection of the 2014 BRFSS occurred at the state level. Data was collected
monthly and data collection varied slightly state by state, as there were state specific questions
and state-selected modules. All interviewers received extensive training provided via a CDC
standardized protocol. Data was collected via computer software, WinCATI (Windows-based
Computer Assisted Telephone Interviewing). Each interview was conducted following a
computerized script and read verbatim. The interview selected the respondent’s answer and the
computer generated the skip pattern, as necessary. Through the design of the software and by
incorporating edits and skip patterns into the WinCATI instrument, interviewer errors, data entry
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errors, and skip errors were reduced (Alaska Department of Health and Social Services, 2016). In
addition, data was cleaned prior to being made publicly available on the CDC’s website.
The validity and reliability of the BRFSS questions have been widely studied.
Pierannunzi, Hu, & Balluz (2013) conducted a systematic review of the literature and found high
validity and reliability among immunization and preventative testing. Burger & Reither (2014)
found sensitivity of influenza vaccination receipt to be 92.9%. Therefore, the data used in this
study was considered to be both valid and reliable.
The 2014 BRFSS database included all of the survey variables and calculated variables.
We included selected demographic data to describe the study sample in detail, including age,
race/ethnicity, marital status, number of children in household, education, employment status,
and income. In order to answer the research questions, the following BRFSS questions were
used:
•

Pregnancy status: “To your knowledge, are you now pregnant?” (CDC, 2015a)

•

Influenza vaccination receipt: “During the past 12 months, have you had either a flu shot
or a flu vaccine that was sprayed in your nose?” (CDC, 2015a)

•

Tdap vaccination receipt: “Since 2005, have you had a tetanus shot? (If yes, ask, “Was
the Tdap, the tetanus shot that also has pertussis or whooping cough vaccine?”) (CDC,
2015a)

The variable TETANUS was included in the 2014 BRFSS additional modules. Since states were
allowed to choose whether the module was included or not, TETANUS module was only
selected for use in the following states in 2014: Georgia, Mississippi, Rhode Island, Tennessee,
Vermont, and Virginia.
Data Analysis
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The 2014 BRFSS database was downloaded into SPSS version 23. The study sample was
selected using the eligibility criteria. Descriptive statistical analysis was performed on each study
variable. Since all variables were categorical, frequencies and percentages were calculated
(Table 1). Chi-squared analysis was used to address the research hypotheses.
Prior to data analysis, multiple variables were transformed. Age was recoded as 18-34
years and 35-44 years. TETANUS were transformed to combine “Yes, received Tdap” and “Yes,
received tetanus shot but not sure what type” to Yes and “No, did not receive any tetanus since
2005” was no and “Yes, received tetanus, but not Tdap” was coded as missing. For all analyses,
alpha was set at 0.01 to account for the large sample size.
Ethical Considerations
The George Washington University’s Institutional Review Board determined this was a
non-human subject study and was exempt from IRB review (GWU IRB communication, 2016).
Results
The 2014 BRFSS included 66,894 childbearing-aged women. Of the women in the
sample, 60.0% were married and 68.9% had children living in the household. Most women
(70.0%) completed more than high school and were employed outside of the home (64.8%),
with 58.8% of women having a total household income greater than $35,001 annually. Only
3.8% of the 66,894 childbearing-aged women were pregnant during the 2014 BRFSS data
collection. Most of the women were 18 to 34 years (53.6%) and were largely white, nonHispanic (70.4%). Thirty-seven percent of the sample population received an influenza
vaccination. Of the 3,861 women who were asked and answered the Tdap question, 59.0%
received the Tdap vaccination since 2005. Table 1 outlines demographics of the sample.
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Demographic variables are usually considered in all studies as they often are confounding
variables for results. The association between marital status, living with children, income and
education provide important information about variables that could be influential to
immunization. Although these are not the primary variables in this study, we feel they should be
included in the results and discussion. Among women who were married or living with a partner,
39.8% received an influenza vaccination while 32.1% of women who were not married received
an influenza vaccination (X2=382.28, p<0.001). Similarly, 38.2% of women who had children
living in the household received the vaccination while 33.3% who did not have children received
the vaccination (X2=140.39, p<0.001). Among women who earned more than $75,000, 46.8%
received an influenza vaccination in the past year (X2=1173.87, p<0.001). Table 2 outlines
additional demographic characteristics by influenza vaccination status.
Similarly, an analysis of demographic characteristics by Tdap vaccination receipt
revealed several significant variables. Martial status and children living in household variables
were not found to be significant predictors of receipt of Tdap vaccination. Education (X2=41.28,
p<0.001), employment status (X2=8.51, p=0.004), and income (X2=40.99, p<0.001) were found
to be statistically significant predictors of Tdap vaccination receipt. Table 3 outlines the results
of this analysis.
X2 tests were used to evaluate the hypotheses. Among women who were pregnant, 43.1%
received an influenza vaccination while the rate was 36.5% among non-pregnant women of
child-bearing age (X2=43.69, p<0.001). By age group, the influenza vaccination rate was 35.1%
in past year for women who were 18-34 years old while the rate was 38.5% among women who
were 35-44 years old (X2=288.47, p<0.001). There was also significant differences among
racial/ethnic groups, with 30.5% of black, 31.6% of Hispanic, 38.8% of white, and 41.0% of
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Asian women received an influenza vaccination in the past 12 months (X2 = 288.47, p<0.001).
Table 4 outlines the results of this analysis.
For Tdap vaccination, pregnancy status was not significant at the 0.01 level. For
childbearing-aged women who were pregnant, 68.3% received the vaccine while for women who
were not pregnant, the rate was 58.6% (X2=5.28, p=0.022). Age was significant. For women
who were 18-34 years old, 61.3% had received the vaccine since 2005; while women who were
35-44 years old 56.8% received the vaccine (X2=8.15, p=0.004). Among the racial/ethnicity
groups, 45.3% of black women, 48.5% of Asian women, 53.3% of Hispanic woman, and 63.3%
of white women received a Tdap vaccination since 2005 (X2 = 84.93, p<0.001). Table 5 outlines
the results of this analysis.
Discussion
In alignment with previously reported influenza and Tdap vaccination rates among all
adults, this study found the vaccination rates among childbearing-aged women were 36.7% for
influenza and 59.0% for Tdap. These rates were below the national goals of 70% for influenza
vaccination as defined by Healthy people 2020 (2016). HealthyPeople 2020 has not outlined a
national Tdap vaccination goal at this time, but does have a goal to reduce infant pertussis cases
(2016).
In this study, we found that women who were married or living with a partner received
the influenza vaccination 7.7% more than those who were not married and 4.9% more if they had
children living in their home versus no children living at home. Some possible reasons for these
results may be partners are more likely to obtain vaccinations together, receive vaccination
through their workplace, or increased home pressure to receive vaccinations to prevent disease in
the home. Individuals living with children in the home may be more likely to receive an
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influenza vaccination due to the potential health risk of influenza for children. However, after a
review of the literature, no other studies identified marital status or children living in the home as
predictors of influenza vaccination receipt.
The largest demographic discrepancies were noted among education and income. Those
with more than high school education were 11.3% more likely to receive an influenza vaccine
than those who had less than high school education. Similarly, those with a household income
over $75,000 were 16.8% more likely to receive an influenza vaccination than those who made
less than $35,000 annual household income. Therefore, interventions to improve vaccination
rates should focus on providers and less educated, lower income childbearing-aged women to
improve overall vaccination rates and reduce disease burden and costs.
Further review of our results, suggests pregnancy status improves influenza vaccination
rates and aligns with findings from other studies (Kharbanda, et al., 2013). The reason for this
higher rate could be due to increased doctor’s appointments during pregnancy and frequent
reminders by healthcare providers to receive vaccination (Lu, et al., 2015). In addition, women
who were older (35-44 year old) were more likely to have received the influenza vaccine than
their younger counterpart (18-34 year old). This finding is consistent with the literature in that
older adults had higher rates of receiving this vaccine than younger adults (Lu, et al., 2015). This
suggests that the increasing rates of influenza vaccination may be linear with growing age,
regardless of age groups.
The greatest discrepancies noted were among racial categories with non-Hispanic blacks
receiving the vaccination 10.5% less than Asians. The disparities identified may highlight
different patient beliefs and practices regarding preventative medicine. Kharbanda, et al. (2013)
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also suggested the lower influenza vaccination coverage among non-Hispanic blacks may be due
to a greater mistrust in the modern medical system.
For Tdap vaccination, the largest demographic discrepancy was noted among education.
Those with more than high school education were 18.2% more likely to receive a Tdap vaccine
than those who had less than high school education. While the differences were not as large,
income and employment status varied as well. Women with an annual household income of
$75,000 or more were 12.6% more likely to receive a Tdap vaccination than those who had a
household income of $35,000. Women employed outside of the home were 5% more likely to
receive a Tdap vaccination than those who were not employed. As with influenza vaccination,
interventions to improve Tdap vaccination rates should focus on providers and less educated,
lower income childbearing-aged women to improve overall Tdap vaccination rates and reduce
disease burden and costs.
Pregnancy status was not found to be a significant predictor for receipt of Tdap
vaccination in this study. This result does not align with other findings of similar studies, which
found pregnancy status to increase Tdap vaccination rates (Kharbanda, 2013; O’Halloran, et al.,
2016). One of the reasons for the discrepancy could be a small sample size since Tdap
vaccination questions were only asked in six states, rather than all 50 states and the District of
Columbia. For age, 18-34 year old women were 4.5% more likely to receive a Tdap vaccination
than women who were 35-44 years old. A portion of this discrepancy may be accounted for by
the large number of individuals who would have received this vaccination while under 18 years
old in order to attend school or participate in sports (O’Halloran, et al., 2016). Finally, there was
an 18% gap between white and black childbearing-aged women regarding receipt of Tdap
vaccination. Again, the discrepancy may be accounted for by an overall distrust in the modern
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medical system or a lack of patient education regarding need of vaccination (Kharbanda, 2013;
O’Halloran, et al., 2016). Therefore, differences were only noted among childbearing-aged
women by age group and race, not by pregnancy status.
Limitations
Several limitations of this study should be noted. Since this was a secondary data analysis,
the researchers were limited by the parameters of previously collected data. Second, since
influenza and Tdap vaccination status were self-reported, recall bias may have affected results.
Third, since the Tdap questions were state-selected questions, with participation from only six
states, the sample size for Tdap vaccines was noticeable smaller than the influenza vaccination
and the results may not be generalizable to the general population. In addition, some women
were excluded from the analysis due to their inability to clearly identify whether they had
received Tdap or Td vaccination. Finally, the smaller sample size of pregnant women regarding
Tdap vaccination rates may also account for why pregnancy status did not have a significant
result.
Implications/Recommendations
Despite the limitations, this study reveals important information about influenza and
Tdap vaccination rates among childbearing-aged women. The findings suggest a need for
targeted interventions to improve influenza and Tdap vaccination rates among childbearing-aged
women due to the potential complications from both influenza and pertussis to pregnant women
and young children (Fortner, et al., 2012; Suryadevara & Domachowske, 2015; Yuen & Tarrant,
2014). With recent guideline changes to improve influenza and Tdap vaccination rates among
childbearing-aged women, Tdap vaccination rates should continue to rise. However, an increase
in Tdap vaccination rates will only occur if patients understand the need for the vaccine and
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receive vaccinations per current recommendations. Therefore, nurse practitioners, physician
assistants, and physicians must work together to improve awareness within their patient
populations. Therefore, interventions designed to improve vaccination rates need to target both
providers and high-risk patient populations. Provider interventions to consider for further testing
may include raising awareness of current vaccine recommendations for childbearing-aged
women among providers, a reminder prompt in the patient’s medical record to document current
vaccination status, include questions about last vaccination of influenza and Tdap/Td on patient
intake forms, or a conversation starter tool to aid providers with conversations about vaccination
status. Patient interventions to consider for further study may include hanging flyers in locations
where childbearing-aged women are likely to be (grocery stores, gym, daycares, workplaces,
shopping malls/stores, etc.), working with local community health departments to assess
vaccination status in their communities, or collaborating with places of employment/health plans
to promote vaccination receipt. Increasing influenza and Tdap vaccinations improves healthcare
utilization and satisfies Andersen’s Behavioral Model of Medical Care Utilization.
Therefore, further studies are needed to fully understand why vaccination rates were
below current HealthyPeople 2020 goals and what interventions are effective in improving
influenza and Tdap vaccination rates among childbearing-aged women. Additional research
regarding disparities among the demographic variables may provide more information to aid in
intervention design. Ultimately, through tested interventions, influenza and Tdap vaccination
rates will improve and reduce the burden and costs associated with influenza and pertussis
among childbearing-aged women, fetuses, infants, and children.
Conclusions
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While this study analyzed influenza and Tdap vaccination rates among childbearing aged
women within a large national database, further research is needed to better understand identified
discrepancies. In addition, the results of this study should be compared with similar national
vaccination databases in order to obtain a more complete picture of vaccination rates among
childbearing-aged women. Finally, interventions should be designed to target providers as well
as higher-risk groups, such as, lower income, less educated, non-Hispanic blacks, to improve
overall influenza and Tdap vaccination rates.
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Table 1
Demographics of the Sample (N=66,894)
Demographic Variable
Marital status (n=66,386)
Married or living with partner
Not married
Children in household (n=66,359)
Children living in the household
No children living in the household
Education (n=66,389)
Less than high school
High school graduate
More than high school
Employment Status (n=66,146)
Employed outside the home
Not employed
Income (n=58,059)
Less than $35,000
$35,001 to $75,000
More than $75,000
Pregnancy Status (n=64,575)
Yes, currently pregnant
Not currently pregnant
Age (n=66,646)
18 to 34 years
35 to 44 years
Race (n=61,917)
White, non-Hispanic
Black, non-Hispanic
Asian
Hispanic
Influenza Vaccination (n=62,752)
Yes, received influenza vaccination in past 12 mo
No, did not receive influenza vaccination in past
12 mo
Tdap Vaccination (n=3,861)
Yes, received Tdap since 2005
No, did not receive Tdap since 2005

Frequency

Percentage

39,814
26,572

60.0%
40.0%

45,751
20,608

68.9%
31.1%

4,984
14,950
46,455

7.5%
22.5%
70.0%

42,889
23,257

64.8%
35.2%

23,901
16,340
17,818

41.2%
28.1%
30.7%

2,472
62,103

3.8%
96.2%

35,691
30,955

53.6%
46.4%

43,581
6,563
2,193
9,580

70.4%
10.6%
3.5%
15.5%

23,029
39,723

36.7%
59.4%

2,278
1,583

59.0%
41.0%
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Table 2
Comparison of Influenza vaccination by Demographic Characteristics
Influenza vaccination
No
Yes
Marital status (n=62492)
Married or living with partner
Not married
Children in household (n=62559)
Children living in the household
No children living in the household
Education (n=62656)
Less than high school
High school graduate
More than high school
Employment Status (n=62542)
Employed outside the home
Not employed
Income (n=55434)
Less than $35,000
$35,001 to $75,000
More than $75,000

22,686 (60.2%)
16,860 (67.9%)

14,985 (39.8 %)
7,961 (32.1%)

26,630 (61.8%)
12,979 (66.7%)

16,474 (38.2%)
6,474 (33.3%)

3,256 (71.4%)
9,848 (70.7%)
26,552 (60.1%)

1,304 (28.6%)
4,077 (29.3%)
17,619 (39.9%)

24,824 (61.2%)
14,772 (67.2%)

15,728 (38.8%)
7,218 (32.8%)

15,772 (70.0%)
9,797 (62.5%)
9,153 (53.2%)

6,769 (30.0%)
5,889 (37.5%)
8,054 (46.8%)

X2

P-value

382.28

p<0.001

140.39

p<0.001

652.26

p<0.001

218.10

p<0.001

1173.87

p<0.001
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Table 3
Comparison of Tdap Vaccination by Demographic Characteristics
Tdap vaccination
No
Yes
Marital status (n=3844)
Married or living with partner
Not married
Children in household (n=3850)
Children living in the household
No children living in the household
Education (n=3855)
Less than high school
High school graduate
More than high school
Employment Status (n=3853)
Employed outside the home
Not employed
Income (n=3454)
Less than $35,000
$35,001 to $75,000
More than $75,000

876 (39.5%)
701 (43.1%)

1,343 (60.5%)
924 (56.9%)

1,108 (41.6%)
470 (39.7%)

1,557 (58.4%)
715 (60.3%)

147 (56.3%)
404 (45.2%)
1,029 (38.1%)

114 (43.7%)
489 (54.8%)
1,672 (61.9%)

1,032 (39.4%)
548 (44.4%)

1,586 (60.6%)
687 (55.6%)

662 (47.0%)
385 (39.6%)
368 (34.4%)

748 (53.0%)
588 (60.4%)
703 (65.6%)

X2

P-value

5.20

p=0.023

1.24

P=0.265

41.38

p<0.001

8.51

p=0.004

40.99

p<0.001
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Table 4
Comparison of Influenza Vaccination Rate by Pregnancy, Age, and Race/Ethnicity
Influenza vaccination
No
Yes
Pregnant (n=62507)
Yes
No
Age in years (n=62560)
18-34
35-44
Race/Ethnicity (n=58186)
White
Black
Asian
Hispanic

1,369 (56.9%)
38,194 (63.5%)

1,036 (43.1%)
21,908 (36.5%)

21,639 (64.9%)
17,972 (61.5%)

11,710 (35.1%)
11,239 (38.5%)

25,416 (61.2%)
4,220 (69.5%)
1,147 (59.0%)
5,933 (68.4%)

16,083 (38.8%)
1,848 (30.5%)
798 (41.0%)
2,741 (31.6%)

X2

P-value

43.69

p<0.001

75.77

p<0.001

288.47

p<0.001
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Table 5
Comparison of Tdap Vaccination Rate by Pregnancy, Age, and Race/Ethnicity
Tdap vaccination
No
Yes
Pregnant (n=3854)
Yes
No
Age in years (n-3854)
18-34
35-44
Race/Ethnicity (n=3711)
White
Black
Asian
Hispanic

45 (31.7%)
1,535 (41.4%)

97 (68.3%)
2,177 (58.6%)

736 (38.7%)
842 (43.2%)

1,168 (61.3%)
1,108 (56.8%)

964 (36.7%)
417 (54.7%)
34 (51.5%)
119 (46.7%)

1,663 (63.3%)
346 (45.3%)
32 (48.5%)
136 (53.3%)

X2

P-value

5.28

p=0.022

8.15

p=0.004

84.93

p<0.001
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Figure 1. Andersen’s Behavioral Model of Medical Care Utilization, Phase 4 (Andersen, 1995).
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Figure 2. Concept map for dependent variable FLUSHOT6
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Figure 3. Concept map for dependent variable TETANUS
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Appendix A
Variable names, Theoretical definitions, and Operational definitions
Variables
Dependent variables
FLUSHOT6

TETANUS
Independent variables
PREGNANT
AGE_AMA

_RACE

Theoretical definition

Operational definition

Receipt of influenza
vaccination (either shot or
nasal mist) in past 12
months.
Receipt of tetanus/Tdap
vaccine

1 = Yes; 2 = No

Respondent’s current
pregnancy status
Transformed variable to
create two age groups based
on diagnosis of advanced
maternal age
A calculated variable to
categorize race and
ethnicity into groups.

1 = Yes, currently pregnant
2 = Not currently pregnant
1 = 18 to 34 years
2 = 35 to 44 years

Additional demographic variables
MARITAL
Current marital status
CHILDREN

EDUCA

EMPLOY1
INCOME2

Other variables
_STATE

Dichotomous variable to
assess presence or absence
of children less than 18
years of age living in
household
Highest grade or year of
school completed by
respondent
Employment status
Annual household income
from all sources

Identifies answers by state

1 = Yes, received Tdap
2 = No, did not receive Tdap since 2005

Only categories included in this study are
listed below:
1 = White only, non-Hispanic
2 = Black only, non-Hispanic
3 = Asian only, non-Hispanic
8 = Hispanic
1 = Married or living with partner
2 = Not married
1= Children in the household
2 = No children in the household

0 = Less than high school
1 = High school graduate
2 = More than high school
1 = Employed outside home
2 = Not employed
1 = Less than $35,000
2 = $35,001 to $75,000
3 = More than $75,000
Each state is listed alphabetically
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Appendix B
Codebook

Dependent variables
FLUSHOT6
Section: 11.1 Immunization
Column: 202
Description: During the past 12 months, have you had either a flu shot or a flu vaccine that was
sprayed in your nose?
Value
1
2
7, 9, Blank

Value Label
Yes
No
Missing

TETANUS
Module: 9.1
Column: 345
Description: Since 2005, have you had a tetanus shot? (If yes, ask “Was the Tdap, the tetanus
shot that also has pertussis or whopping cough vaccine?”)
Value
1
2
7, 9, Blank

Value Label
Yes, received Tdap
No, did not receive any tetanus since 2005
Missing

Independent variables
PREGNANT
Section: 8.22
Column: 179
Description: To your knowledge, are you now pregnant?
Value
1
2
7, 9, BLANK

Value Label
Yes
No
Missing

_AGE5YR
Section: Demographics, calculated variables
Description: Calculated variable for fourteen-level age categories.
Value
Value Label
1
Age 18 to 34 years
2
Age 35 to 44 years
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Missing

_RACE
Section: Demographics, calculated variables
Description: Calculated variable for race.
Value
1
2
4
8
9, Blank

Value Label
White, non-Hispanic
Blacks, non-Hispanic
Asian only, non-Hispanic
Hispanic
Missing

Demographic variables:
MARITAL
Section: 8.6
Column: 147
Description: Are you …?
Value
1
2
9, BLANK

Value Label
Married or living with partner
Not married
Missing

CHILDREN
Section: 8.7
Column: 148-149
Description: How many children less than 18 years of age live in your household?
Value
1
2
99, BLANK

Value Label
Children living in household
No children living in household
Missing

EDUCA
Section: 8.8
Column: 150
Description: What is the highest grade or year of school you completed?
Value
0
1
2
9, BLANK

Value Label
Less than high school
High school graduate
More than high school
Missing
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EMPLOY1
Section: 8.9
Column: 151
Description: Are you currently…?
Value
1
2
9, BLANK

Value Label
Employed outside of the home
Not employed
Missing

INCOME2
Section: 8.10
Column: 152-153
Description: Is your annual household income from all sources:
Value
1
2
3
77, 99, BLANK

Value Label
Less than $35,000
$35,001 to $75,000
More than $75,000
Missing

